Gene expression profiling of multiple myeloma plasma cells allows identification of potential molecular determinants of lytic bone disease.

被引:0
|
作者
Zhan, FH
Randolph, C
Suva, L
Barlogie, B
Epstein, J
Shaughnessy, J
机构
[1] Univ Arkansas Med Sci, Dept Orthopaed, Little Rock, AR 72205 USA
[2] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
782
引用
收藏
页码:208A / 208A
页数:1
相关论文
共 50 条
  • [1] Myeloma cells cultivate megakaryocytes to promote lytic bone disease.
    Yaccoby, S
    Saba, R
    Kozlowska, E
    Ge, Y
    Ling, W
    Cottler-Fox, M
    Barlogie, B
    Tricot, G
    BLOOD, 2005, 106 (11) : 701A - 701A
  • [2] GENE EXPRESSION PROFILING OF MULTIPLE MYELOMA: IMPLICATIONS FOR A MOLECULAR CLASSIFICATION OF THE DISEASE
    Todoerti, K.
    Agnelli, L.
    Fabris, S.
    Verdelli, D.
    Nobili, L.
    Ciceri, G.
    Baldini, L.
    Morabito, F.
    Callea, V
    Palumbo, A.
    Deliliers, Lambertenghi G.
    Lombardi, L.
    Neri, A.
    HAEMATOLOGICA, 2008, 93 : S30 - S30
  • [3] Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
    Ria, Roberto
    Todoerti, Katia
    Berardi, Simona
    Coluccia, Addolorata Maria Luce
    De Luisi, Annunziata
    Mattioli, Michela
    Ronchetti, Domenica
    Morabito, Fortunato
    Guarini, Attilio
    Petrucci, Maria Teresa
    Dammacco, Franco
    Ribatti, Domenico
    Neri, Antonino
    Vacca, Angelo
    CLINICAL CANCER RESEARCH, 2009, 15 (17) : 5369 - 5378
  • [4] Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells
    Zhan, FH
    Hardin, J
    Kordsmeier, B
    Bumm, K
    Zheng, MZ
    Tian, EM
    Sanderson, R
    Yang, Y
    Wilson, C
    Zangari, M
    Anaissie, E
    Morris, C
    Muwalla, F
    van Rhee, F
    Fassas, A
    Crowley, J
    Tricot, G
    Barlogie, B
    Shaughnessy, J
    BLOOD, 2002, 99 (05) : 1745 - 1757
  • [5] Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease
    Magrangeas, F
    Nasser, V
    Avet-Loiseau, H
    Loriod, B
    Decaux, O
    Granjeaud, S
    Bertucci, F
    Birnbaum, D
    Nguyen, C
    Harousseau, JL
    Bataille, R
    Houlgatte, F
    Minvielle, S
    BLOOD, 2003, 101 (12) : 4998 - 5006
  • [6] Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling
    Chng, Wee J.
    Kumar, Shaji
    VanWier, Scott
    Ahmann, Greg
    Price-Troska, Tammy
    Henderson, Kim
    Chung, Tae-Hoon
    Kim, Seungchan
    Mulligan, George
    Bryant, Barbara
    Carpten, John
    Gertz, Morie
    Rajkumar, S. Vincent
    Lacy, Martha
    Dispenzieri, Angela
    Kyle, Robert
    Greipp, Philip
    Bergsagel, P. Leif
    Fonseca, Rafael
    CANCER RESEARCH, 2007, 67 (07) : 2982 - 2989
  • [7] Integrating cytogenetics and gene expression profiling in the molecular analysis of Multiple Myeloma
    John D. Shaughnessy
    Bart Barlogie
    International Journal of Hematology, 2002, 76 : 59 - 64
  • [8] Integrating cytogenetics and gene expression profiling in the molecular analysis of multiple myeloma
    Shaughnessy, JD
    Barlogie, B
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 2) : 59 - 64
  • [9] Resveratrol analogs as potential treatment of multiple myeloma and bone related disease. Effect on myeloma cells, osteoclasts and osteoblasts in vitro
    Kupisiewicz, K.
    Boissy, P.
    Soe, K.
    Abdallah, B.
    KasseM, M.
    Plesner, T.
    Delaisse, J.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S65 - S65
  • [10] Toward the identification of distinct molecular and clinical entities of multiple myeloma using global gene expression profiling
    Zhan, FH
    Barlogie, B
    Shaughnessy, J
    SEMINARS IN HEMATOLOGY, 2003, 40 (04) : 308 - 320